Please use this identifier to cite or link to this item: https://doi.org/10.1021/ml200067t
Title: Exploring aigialomycin D and its analogues as protein kinase inhibitors for cancer targets
Authors: Xu, J.
Chen, A.
Go, M.-L. 
Nacro, K.
Liu, B.
Chai, C.L.L. 
Keywords: Aigialomycin D
CDK2
kinase inhibitor
MNK
resorcylic acid lactone
Issue Date: 8-Sep-2011
Citation: Xu, J., Chen, A., Go, M.-L., Nacro, K., Liu, B., Chai, C.L.L. (2011-09-08). Exploring aigialomycin D and its analogues as protein kinase inhibitors for cancer targets. ACS Medicinal Chemistry Letters 2 (9) : 662-666. ScholarBank@NUS Repository. https://doi.org/10.1021/ml200067t
Abstract: The natural product aigialomycin D (1) is a member of the resorcylic acid lactone (RAL) family possessing protein kinase inhibitory activities. This paper describes the synthesis of aigialomycin D and a series of its analogues and their activity for the inhibition of protein kinases related to cancer pathways. A preliminary study of these compounds in the inhibition of CDK2/cyclin A kinase has found that aigialomycin D and analogues 11 and 23 are moderate CDK2/cyclin A inhibitors with IC 50 values of ca. 20 μM. Kinase profiling of aigialomycin D against a panel of kinases has led to the identification of MNK2 as a promising target (IC 50 = 0.45 μM), and preliminary structure-activity relationship studies have been carried out to identify the essential functional groups for activity. © 2011 American Chemical Society.
Source Title: ACS Medicinal Chemistry Letters
URI: http://scholarbank.nus.edu.sg/handle/10635/105945
ISSN: 19485875
DOI: 10.1021/ml200067t
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

17
checked on May 17, 2018

WEB OF SCIENCETM
Citations

15
checked on May 9, 2018

Page view(s)

35
checked on May 18, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.